Aratana Therapeutics Forecast and Stock Analysis
Technical PETX stock analysis for February 15, 2019.
| Shorts | n/a |
| Cash | n/a |
| Loans | n/a |
| Beta | 1.42 |
| ROA | -15.31 |
Aratana Therapeutics gained 2.55% in the last trading day, rising from $4.31 to $4.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days and is down by -0.45% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 47 626 more shares were traded than the day before. In total, 347 488 shares bought and sold for approximately $1.54 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the PETX stock was $4.42. This is 2.55% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 4.65% from a day low at $4.30 to a day high of $4.50.
30 day high of the PETX stock price was $4.59 and low was $3.82.
90 day high was $6.77 and low was $3.82.
52 week high for the Aratana Therapeutics - $7.16 and low - $3.67.
Trend
Aratana Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.55% during the next 3 months and, with 90% probability hold a price between $1.83 and $3.28 at the end of this period.
Signals
A buy signal was issued from a pivot bottom point on Wednesday February 13, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aratana Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $4.82. On a fall, the stock will find some support from the short-term average at $4.30. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Access today's Top 5 Golden Star Companies
Relative Strength Index (RSI)
RSI14 is 61 and the stock is currently not being overbought or oversold
Support & Resistance
Aratana Therapeutics finds support from accumulated volume at $4.37.
Risk
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.20 (4.65%) between high and low. For the last week, the stock has had a daily average volatility of 3.74%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Overall risk:
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Aratana Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
